- Report
- April 2025
- 200 Pages
Global
From €2181EUR$2,490USD£1,893GBP
- Report
- September 2025
- 142 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- June 2025
- 325 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- May 2025
- 138 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- May 2025
- 160 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- November 2023
- 74 Pages
From €2584EUR$2,950USD£2,242GBP
- Report
- January 2019
- 348 Pages
Global
From €3854EUR$4,400USD£3,345GBP
- Training
- 4 Hours
Global
€3065EUR$3,500USD£2,661GBP
- Training
- 3 Hours
Global
€3065EUR$3,500USD£2,661GBP
- Training
- 6 Hours
Global
The Urine Drug Test market is a segment of the Drug Abuse Screening industry. It is used to detect the presence of drugs in a person's system, typically through a sample of their urine. Urine Drug Tests are used to detect the presence of illicit drugs, as well as prescription medications that have been abused. The tests are used to identify drug use in a variety of settings, including workplaces, schools, and medical facilities. Urine Drug Tests are typically conducted using immunoassay technology, which uses antibodies to detect the presence of drugs in a sample. The results of the test are typically reported in a matter of minutes.
Some companies in the Urine Drug Test market include Alere, Siemens, Roche Diagnostics, and Abbott Laboratories. Show Less Read more